Soleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Purchases $116,424.00 in Stock

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Rating) major shareholder Perceptive Advisors Llc bought 25,200 shares of Soleno Therapeutics stock in a transaction on Friday, May 19th. The stock was acquired at an average cost of $4.62 per share, with a total value of $116,424.00. Following the acquisition, the insider now owns 1,889,655 shares of the […]

Related Keywords

,Millennium Management ,Dimensional Fund Advisors ,Carlyle Group Inc ,Securities Exchange Commission ,Nasdaq ,Soleno Therapeutics Inc ,Jpmorgan Chase Co ,Perceptive Advisors Llc ,Renaissance Technologies ,Soleno Therapeutics ,Get Rating ,Exchange Commission ,Advisors Llc ,Therapeutics Stock Down ,Fund Advisors ,Diazoxide Choline Controlled Release ,Prader Willi Syndrome ,Soleno Therapeutics Daily ,Nasdaq Slno ,Slno ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,